ORIGINAL RESEARCH
Published on 11 Feb 2022
Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation
doi 10.3389/fimmu.2022.829670
- 3,368 views
- 11 citations
- Frontiers in Immunology
- Alloimmunity and Transplantation
- Research Topics
- Moving Towards Allogeneic Cellular Therapies: Opportunities and Challenges
Moving Towards Allogeneic Cellular Therapies: Opportunities and Challenges
42k
Total downloads
186k
Total views and downloads
Articles
CLINICAL TRIAL
Published on 15 Dec 2021
Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis
doi 10.3389/fimmu.2021.756495
- 3,174 views
- 14 citations
PERSPECTIVE
Published on 03 Aug 2021
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia
doi 10.3389/fimmu.2021.695051
- 4,696 views
- 13 citations
ORIGINAL RESEARCH
Published on 22 Jul 2021
Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment
doi 10.3389/fimmu.2021.690467
- 5,079 views
- 13 citations
REVIEW
Published on 10 Jun 2021
Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review
doi 10.3389/fimmu.2021.688460
- 7,609 views
- 16 citations
REVIEW
Published on 03 Mar 2021
Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
doi 10.3389/fimmu.2021.640082
- 60,511 views
- 100 citations
ORIGINAL RESEARCH
Published on 29 Jan 2021
HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for “Off-the-Shelf” Immunotherapy
doi 10.3389/fimmu.2020.586168
- 16,371 views
- 37 citations
REVIEW
Published on 08 Jan 2021
Allogeneic CAR Cell Therapy—More Than a Pipe Dream
doi 10.3389/fimmu.2020.618427
- 29,801 views
- 98 citations
ORIGINAL RESEARCH
Published on 08 Jan 2021
Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19
doi 10.3389/fimmu.2020.598402
- 4,817 views
- 30 citations
REVIEW
Published on 11 Nov 2020
Off-the-Shelf Allogeneic T Cell Therapies for Cancer: Opportunities and Challenges Using Naturally Occurring “Universal” Donor T Cells
doi 10.3389/fimmu.2020.583716
- 19,707 views
- 41 citations
REVIEW
Published on 21 Oct 2020
How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation
doi 10.3389/fimmu.2020.583564
- 2,890 views
- 7 citations
ORIGINAL RESEARCH
Published on 19 Oct 2020
ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma
doi 10.3389/fimmu.2020.581468
- 4,150 views
- 30 citations
